Evidence-based application of cardiac magnetic resonance and cardiac computed tomography for primary diagnosis of stable coronary artery disease with special attention to disease management programs and the German national medical care guidelines;Evidenzbasierter einsatz von kardio-MR und kardio-CT in der primärdiagnostik der stabilen koronaren herzkrankheit unter besonderer berücksichtigung des Disease-Management-Programms (DMP) KHK und der nationalen versorgungsleitlinie

Herz

Volumn 32, Issue 2, 2007, Pages 139-158

  Silber, Sigmund ^a   Richartz, Barbara M ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cardiac CT; Cardiac MR; Myocardial ischemia; Risk assessment

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANGIOCARDIOGRAPHY; ARTICLE; ARTIFACT; CARDIAC PATIENT; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; ECG ABNORMALITY; EVIDENCE BASED MEDICINE; EXERCISE ELECTROCARDIOGRAPHY; HEART CATHETERIZATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART SCINTISCANNING; HIGH RISK PATIENT; HUMAN; NEEDS ASSESSMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PREDICTION; PRIMARY PREVENTION; PROBABILITY; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SCORING SYSTEM; STROKE; THORAX PAIN; TREATMENT PLANNING; CORONARY ARTERY ATHEROSCLEROSIS; GERMANY; INTERNATIONAL COOPERATION; METHODOLOGY; PUBLIC HEALTH; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; STANDARD;

CORONARY ARTERIOSCLEROSIS; EVIDENCE-BASED MEDICINE; GERMANY; HUMANS; INTERNATIONALITY; MAGNETIC RESONANCE IMAGING; NATIONAL HEALTH PROGRAMS; PRACTICE GUIDELINES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34248597918     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-007-2973-4     Document Type: Article

References (150)

1. Anderson GF, Chu E. Expanding priorities - confronting chronic disease in countries with low income. N Engl J Med 2007;356:209-11.
2. Statistisches Bundesamt Deutschland. Fachserie 12 - Reihe 4: Todesursachen in Deutschland. Wiesbaden: Statistisches Bundesamt, 2006 (http://www.destatis.de).
3. Silber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005;26:804-47.
4. Bassand JP, Danchin N, Filippatos G, et al. Implementation of reperfusion therapy in acute myocardial infarction. A policy statement from the European Society of Cardiology. Eur Heart J 2005;26:2733-41.
5. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 2007;297:177-86.
6. Bruckenberger E. Herzbericht 2005. 18. Bericht. Sektorenü bergreifende Versorgungsanalyse zur Kardiologie und Herzchirurgie in Deutschland. Mit vergleichenden Daten aus Österreich und der Schweiz. Hannover: Selbstverlag, 2006.
7. Iglehart JK. The new era of medical imaging - progress and pitfalls. N Engl J Med 2006;354:2822-8.
8. Gibbons RJ, Eckel RH, Jacobs AK. The utilization of cardiac imaging. Circulation 2006;113:1715-6.
9. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (executive summary). Eur Heart J 2003;24:1601-10.
10. Fox K, Garcia MA, Ardissino D, et al. Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006;27:1341-81.
11. Pennell DJ, Sechtem UP, Higgins CB, et al. Clinical indications for cardiovascular magnetic resonance (CMR): consensus panel report. Eur Heart J 2004;25:1940-65.
12. Budoff MJ, Achenbach S, Blumenthal RS, et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation 2006;114:1761-91.
13. Hendel RC, Patel MR, Kramer CM, et al. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/ SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol 2006;48:1475-97.
14. Greenland P, Bonow RO, Brundage BH, et al. ACCF/AHA 2007 Clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain. A report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). Developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 2007;49:378-402.
15. Gohlke H, Albus C, Bönner G, et al. Risikoadjustierte Prävention von Herz- und Kreislauferkrankungen. Clin Res Cardiol 2007:im Druck.
16. Nagel E, Bauer W, Sechtem U, et al. Klinische Indikationen für die kardiovaskuläre Magnetresonanztomographie (CMR) - Positionspapier. Clin Res Cardiol, 2007:im Druck.
17. Bundesärztekammer, Fachgesellschaften AdWM, Kassenärztliche Bundesvereinigung. Nationale Versorgungs-leitlinie Chronische KHK. Berlin: Bundesärztekammer, Fachgesellschaften AdWM, Kassenärztliche Bundesvereinigung, 2006 (http://www.khk.versorgungsleitlinien.de).
18. Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 2002;106:1883-92.
19. Sauer G, Andresen D, Cierpka R, et al. Positionspapier zur Durchführung von Qualitätskontrollen bei Ruhe-, Belastungs- und Langzeit-EKG. Z Kardiol 2005;94:844-57.
20. Nixdorff U, Buck T, Engberding R, et al. Positionspapier zur Qualifikation und Zertifizierung von Untersuchern in der Echokardiographie. Clin Res Cardiol 2006;1:Suppl 2:96-102.
21. Zimmermann R, vom Dahl J, Schäfers M, et al. Positionsbe richt nuklearkardiologische Diagnostik - Update. Z Kardiol 2002;91:88-92.
22. Sechtem U, Fleck E, Baer FM, et al. Empfehlungen für die Qualifikation in kardiovaskulärer Magnetresonanztomo graphie. Z Kardiol 2001;90:442-4.
23. Achenbach S, Schmermund A, Erbel R, et al. Klinische Bedeutung des quantitativen Nachweises von Koronarkalk mit Elektronenstrahltomographie (EBT) und Mehrzeilen-Spiral-Computertomographie (MSCT). Z Kardiol 2003;92:899-907.
24. Gianrossi R, Detrano R, Mulvihill D, et al. Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis. Circulation 1989;80:87-98.
25. Lee TH, Boucher CA. Clinical practice. Noninvasive tests in patients with stable coronary artery disease. N Engl J Med 2001;344:1840-5.
26. Schinkel AF, Bax JJ, Geleijnse ML, et al. Noninvasive evaluation of ischaemic heart disease: myocardial perfusion imaging or stress echocardiography? Eur Heart J 2003;24:789-800.
27. Silber S. Streßechokardiographie versus Myokardszinti graphie: vergleichende Wertigkeit bei koronarer Herzerkrankung. Herz 1996;21:136-41.
28. Klem I, Heitner JF, Shah DJ, et al. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol 2006;47:1630-8.
29. Ishida N, Sakuma H, Motoyasu M, et al. Noninfarcted myocardium: correlation between dynamic first-pass contrast-enhanced myocardial MR imaging and quantitative coronary angiography. Radiology 2003;229:209-16.
30. Giang TH, Nanz D, Coulden R, et al. Detection of coronary artery disease by magnetic resonance myocardial perfusion imaging with various contrast medium doses: first European multi-centre experience. Eur Heart J 2004;25:1657-65.
31. Wolff SD, Schwitter J, Coulden R, et al. Myocardial first-pass perfusion magnetic resonance imaging: a multicenter dose-ranging study. Circulation 2004;110:732-7.
32. Schwitter J. Comparison of MR myocardial perfusion imaging with SPECT in known or suspected coronary artery disease: a multicentre, multivendor dose finding study (IMPACT). Clincial Trial Update Session, Annual Meeting of the European Society of Cardiology (ESC) Stockholm, September 7, 2005.
33. Flohr TG, McCollough CH, Bruder H, et al. First performance evaluation of a dual-source CT (DSCT) system. Eur Radiol 2006;16:256-68.
34. Achenbach S, Ropers D, Kuettner A, et al. Contrast-enhanced coronary artery visualization by dual-source computed tomography - initial experience. Eur J Radiol 2006;57:331-5.
35. Scheffel H, Alkadhi H, Plass A, et al. Accuracy of dual-source CT coronary angiography: first experience in a high pre-test probability population without heart rate control. Eur Radiol 2006;16:2739-47.
36. Johnson TR, Nikolaou K, Wintersperger BJ, et al. Dual-source CT cardiac imaging: initial experience. Eur Radiol 2006;16:1409-15.
37. Schmermund A, Erbel R, Silber S. Age and gender distribution of coronary artery calcium measured by four-slice computed tomography in 2,030 persons with no symptoms of coronary artery disease. The MUNICH registry. Am J Cardiol 2002;90:168-73.
38. Becker CR, Majeed A, Crispin A, et al. CT measurement of coronary calcium mass: impact on global cardiac risk assessment. Eur Radiol 2005;15:96-101.
39. Greenland P, Gaziano JM. Clinical practice. Selecting asymptomatic patients for coronary computed tomography or electrocardiographic exercise testing. N Engl J Med 2003;349:465-73.
40. Thompson GR, Partridge J. Coronary calcification score: the coronary-risk impact factor. Lancet 2004;363:557-9.
41. Raggi P, Callister TQ, Cooil B, et al. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation 2000;101:850-5.
42. Hoff JA, Chomka EV, Krainik AJ, et al. Age and gender distributions of coronary artery calcium detected by electron beam tomography in 35,246 adults. Am J Cardiol 2001;87:1335-9.
43. NCEP. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), final report. Circulation 2002;106:3143-421.
44. Hamon M, Biondi-Zoccai GG, Malagutti P, et al. Diagnostic performance of multislice spiral computed tomography of coronary arteries as compared with conventional invasive coronary angiography: a meta-analysis. J Am Coll Cardiol 2006;48:1896-910.
45. McCollough CH. Patient dose in cardiac computed tomography. Herz 2003;28:1-6.
46. Hausleiter J, Meyer T, Hadamitzky M, et al. Radiation dose estimates from cardiac multislice computed tomography in daily practice: impact of different scanning protocols on effective dose estimates. Circulation 2006;113:1305-10.
47. Silber S. Argumente für die Integrierte Versorgung als Regelversorgung in der Kardiologie. Clin Res Cardiol 2006;95:Suppl 2:II-37-40.
48. Trappe HJ, Löllgen H. Leitlinien zur Ergometrie. Z Kardiol 2000;89:821-31.
49. Jennen E. Diagnostik für die Einschreibung in das DMP KHK. In: Deutscher Hausärzteverband e.V., AOK Bundesverband, Hrsg. Das Hausarzthandbuch zum DMP-KHK. Umsetzung von DMP in der Hausarztpraxis. München: MED.KOMM., 2004:43-8.
50. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med 1979;300:1350-8.
51. Romeo F, Leo R, Clementi F, et al. Multislice computed tomography in an asymptomatic high-risk population. Am J Cardiol 2007;99:325-8.
52. Van Buuren F, Horstkotte D. 21. Bericht über die Leistungs zahlen der Herzkatheterlabore in der Bundesrepublik Deutschland. Clin Res Cardiol 2006;95:383-7.
53. Cannon RO 3rd, Epstein SE. "Microvascular angina" as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol 1988;61:1338-43.
54. Preik M, Kelm M, Strauer BE. Management of the hypertensive patient with coronary insufficiency but without atherosclerosis. Curr Opin Cardiol 2003;18:255-9.
55. Bugiardini R, Bairey Merz CN. Angina with "normal" coronary arteries: a changing philosophy. JAMA 2005;293:477-84.
56. Panting JR, Gatehouse PD, Yang GZ, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002;346: 1948-53.
57. Lüscher TF. The endothelium and cardiovascular disease - a complex relation. N Engl J Med 1994;330:1081-3.
58. Oki T, Tabata T, Yamada H, et al. Left ventricular diastolic properties of hypertensive patients measured by pulsed tissue Doppler imaging. J Am Soc Echocardiogr 1998;11:1106-12.
59. Diamond JA, Phillips RA. Hypertensive heart disease. Hypertens Res 2005;28:191-202.
60. Friedrich J, Tebbe U, Weber M, et al. Prädiktiver Wert eines Ischämietests bei Männern und Frauen mit stabiler Angina pectoris im Klinikalltag. Ergebnisse des Herzkatheter-Re gisters der ALKK. Dtsch Med Wochenschr 2006;131:1078-84.
61. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003;326:1419.
62. Reddy KS. The preventive polypill - much promise, insufficient evidence. N Engl J Med 2007;356:212.
63. Gaziano TA, Opie LH, Weinstein MC. Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet 2006;368:679-86.
64. Stampfer MJ, Hu FB, Manson JE, et al. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 2000;343:16-22.
65. U.S. Preventive Services Task Force. Aspirin for the primary prevention of cardiovascular events: recommendation and rationale. Ann Intern Med 2002;136:157-60.
66. Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005;352:1293-304.
67. Silber S, Böhm M, Gottwick M, et al. Akutes Herzinfarktrisiko bei mangelnder Clopidogrelgabe nach koronarer Stentimplantation. Dtsch Ärztebl 2006;103:A2863-8.
68. Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:1706-17.
69. Kashani A, Phillips CO, Foody JM, et al. Risks associated with statin therapy: a systematic overview of randomized clinical trials. Circulation 2006;114:2788-97.
70. Setoguchi S, Glynn RJ, Avorn J, et al. Statins and the risk of lung, breast, and colorectal cancer in the elderly. Circulation 2007;115:27-33.
71. The Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
72. Thavendiranathan P, Bagai A, Brookhart MA, et al. Primary prevention of cardiovascular diseases with statin therapy: a metaanalysis of randomized controlled trials. Arch Intern Med 2006;166:2307-13.
73. Bonetti PO, Lerman LO, Napoli C, et al. Statin effects beyond lipid lowering - are they clinically relevant? Eur Heart J 2003;24:225-48.
74. Glagov S, Weisenberg E, Zarins CK, et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987;316:1371-5.
75. Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988;12:56-62.
76. Devereux RB, Alderman MH. Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events. Circulation 1993;88:1444-55.
77. Giroud D, Li JM, Urban P, et al. Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Am J Cardiol 1992;69:729-32.
78. Hackett D, Davies G, Maseri A. Pre-existing coronary stenoses in patients with first myocardial infarction are not necessarily severe. Eur Heart J 1988;9:1317-23.
79. Little WC, Constantinescu M, Applegate RJ, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 1988;78:1157-66.
80. Moise A, Lesperance J, Theroux P, et al. Clinical and angiographic predictors of new total coronary occlusion in coronary artery disease: analysis of 313 nonoperated patients. Am J Cardiol 1984;54:1176-81.
81. Nobuyoshi M, Tanaka M, Nosaka H, et al. Progression of coronary atherosclerosis: is coronary spasm related to progression? J Am Coll Cardiol 1991;18:904-10.
82. Proudfit WL, Bruschke VG, Sones FM Jr. Clinical course of patients with normal or slightly or moderately abnormal coronary arteriograms: 10-year follow-up of 521 patients. Circulation 1980;62:712-7.
83. Yokoya K, Takatsu H, Suzuki T, et al. Process of progression of coronary artery lesions from mild or moderate stenosis to moderate or severe stenosis: a study based on four serial coronary arteriograms per year. Circulation 1999;100:903-9.
84. Greenland P, LaBree L, Azen SP, et al. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 2004;291:210-5.
85. Chambless LE, Heiss G, Folsom AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997;146:483-94.
86. O'Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999;340:14-22.
87. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003;23:168-75.
88. Lorenz MW, Markus HS, Bots ML, et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007;115:459-67.
89. Barrett-Connor E, Laughlin GA, Connor C. Coronary artery calcium versus intima-media thickness as a measure of cardiovascular disease among asymptomatic adults (from the Rancho Bernardo Study). Am J Cardiol 2007;99:227-31.
90. Grundy SM, Bazzarre T, Cleeman J, et al. Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: medical office assessment: Writing Group I. Circulation 2000;101:e3-11.
91. The NCEP Expert Panel. Executive summary of The Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
92. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) Study. Circulation 2002;105:310-5.
93. Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987-1003.
94. Keil U, Fitzgerald AP, Gohlke H, et al. Risikoabschätzung tödlicher Herz-Kreislauf-Erkrankungen: die neuen SCORE-Deutschland-Tabellen für die Primärprävention. Dtsch Ärztebl 2005;25:A1808-12.
95. Silber S, Richartz BM. Stellenwert von Kardio-CT und Kardio-MR zur Bestimmung des koronaren Risikos. Z Kardiol 2005;94:Suppl 4:IV/70-80.
96. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-16.
97. Wahle K. Risikostratifizierung und risikoadaptierte Therapie. In: Deutscher Hausärzteverband e.V., AOK Bundesverband, Hrsg. Das Hausarzthandbuch zum DMP-KHK. Umsetzung von DMP in der Hausarztpraxis. München: MED.KOMM., 2004:57-61.
98. SBK. Herzrisiken erkennen und gezielt behandeln - Siemens- Betriebskrankenkasse startet kardiologisches Versorgungs- und Präventionsprojekt "SBK KardioPro". München: SBK, 2006 (http://www.sbk.org/de/service/presse/aktuelle_meldungen/presse.2006.10.20. html).
99. International Task Force for Prevention of Coronary Heart Disease. (http://www.chd-taskforce.de/index_d.htm).
100. Empana JP, Ducimetiere P, Arveiler D, et al. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J 2003;24:1903-11.
101. Nasir K, Michos ED, Blumenthal RS, et al. Detection of high-risk young adults and women by coronary calcium and National Cholesterol Education Program Panel III guidelines. J Am Coll Cardiol 2005;46:1931-6.
102. Wang TJ, Gona P, Larson MG, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006;355:2631-9.
103. Hackam DG, Anand SS. Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA 2003;290:932-40.
104. Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-32.
105. Achenbach S, Nomayo A, Couturier G, et al. Relation between coronary calcium and 10-year risk scores in primary prevention patients. Am J Cardiol 2003;92:1471-5.
106. Anand DV, Lim E, Hopkins D, et al. Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. Eur Heart J 2006;27:713-21.
107. Arad Y, Goodman KJ, Roth M, et al. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J Am Coll Cardiol 2005;46:158-65.
108. Arad Y, Spadaro LA, Goodman K, et al. Predictive value of electron beam computed tomography of the coronary arteries. 19-month follow-up of 1173 asymptomatic subjects. Circulation 1996;93:1951-3.
109. Arad Y, Spadaro LA, Goodman K, et al. Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol 2000;36:1253-60.
110. Becker A, Knez A, Becker C, et al. Prädiktion kardiovaskulärer Ereignisse durch Koronarkalkbestimmung mit der Mehr zeilen-Computertomographie. Dtsch Med Wochenschr 2005;130:2433-8.
111. Hecht HS, Superko HR. Electron beam tomography and National Cholesterol Education Program guidelines in asymptomatic women. J Am Coll Cardiol 2001;37:1506-11.
112. Hopkins PN, Ellison RC, Province MA, et al. Association of coronary artery calcified plaque with clinical coronary heart disease in the National Heart, Lung, and Blood Institute's Family Heart Study. Am J Cardiol 2006;97:1564-9.
113. Hunt ME, O'Malley PG, Vernalis MN, et al. C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis. Am Heart J 2001;141:206-10.
114. Kondos GT, Hoff JA, Sevrukov A, et al. Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults. Circulation 2003;107:2571-6.
115. Möhlenkamp S, Lehmann N, Schmermund A, et al. Prognostic value of extensive coronary calcium quantities in symptomatic males - a 5-year follow-up study. Eur Heart J 2003;24:845-54.
116. Okamura T, Kadowaki T, Sekikawa A, et al. Alcohol consumption and coronary artery calcium in middle-aged Japanese men. Am J Cardiol 2006;98:141-4.
117. Reilly MP, Wolfe ML, Localio AR, et al. C-reactive protein and coronary artery calcification: the Study of Inherited Risk of Coronary Atherosclerosis (SIRCA). Arterioscler Thromb Vasc Biol 2003;23:1851-6.
118. Shaw LJ, Raggi P, Callister TQ, et al. Prognostic value of coronary artery calcium screening in asymptomatic smokers and non-smokers. Eur Heart J 2006;27:968-75.
119. Shaw LJ, Raggi P, Schisterman E, et al. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology 2003;228:826-33.
120. Taylor AJ, Bindeman J, Feuerstein I, et al. Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) Project. J Am Coll Cardiol 2005;46:807-14.
121. Taylor AJ, Burke AP, O'Malley PG, et al. A comparison of the Framingham risk index, coronary artery calcification, and culprit plaque morphology in sudden cardiac death. Circulation 2000;101:1243-8.
122. Taylor AJ, Feuerstein I, Wong H, et al. Do conventional risk factors predict subclinical coronary artery disease? Results from the Prospective Army Coronary Calcium Project. Am Heart J 2001;141:463-8.
123. Vliegenthart R, Oudkerk M, Hofman A, et al. Coronary calcification improves cardiovascular risk prediction in the elderly. Circulation 2005;112:572-7.
124. Vliegenthart R, Oudkerk M, Song B, et al. Coronary calcification detected by electron-beam computed tomography and myocardial infarction. The Rotterdam Coronary Calcification Study. Eur Heart J 2002;23:1596-603.
125. Wang L, Jerosch-Herold M, Jacobs DR Jr, et al. Coronary artery calcification and myocardial perfusion in asymptomatic adults: the MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2006;48:1018-26.
126. Wayhs R, Zelinger A, Raggi P. High coronary artery calcium scores pose an extremely elevated risk for hard events. J Am Coll Cardiol 2002;39:225-30.
127. Wong ND, Hsu JC, Detrano RC, et al. Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events. Am J Cardiol 2000;86:495-8.
128. Pletcher MJ, Tice JA, Pignone M, et al. Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. Arch Intern Med 2004;164:1285-92.
129. Kennedy J, Shavelle R, Wang S, et al. Coronary calcium and standard risk factors in symptomatic patients referred for coronary angiography. Am Heart J 1998;135:696-702.
130. Schmermund A, Bailey KR, Rumberger JA, et al. An algorithm for noninvasive identification of angiographic three-vessel and/or left main coronary artery disease in symptomatic patients on the basis of cardiac risk and electron-beam computed tomographic calcium scores. J Am Coll Cardiol 1999;33:444-52.
131. Rumberger JA, Simons DB, Fitzpatrick LA, et al. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 1995;92:2157-62.
132. Burke AP, Taylor A, Farb A, et al. Coronary calcification: insights from sudden coronary death victims. Z Kardiol 2000;89:Suppl 2:49-53.
133. O'Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation 2000;102:126-40.
134. Honda O, Sugiyama S, Kugiyama K, et al. Echolucent carotid plaques predict future coronary events in patients with coronary artery disease. J Am Coll Cardiol 2004;43:1177-84.
135. Van der Meer IM, Bots ML, Hofman A, et al. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. Circulation 2004;109:1089-94.
136. Criqui MH, Fronek A, Barrett-Connor E, et al. The prevalence of peripheral arterial disease in a defined population. Circulation 1985;71:510-5.
137. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286:1317-24.6
138. Diehm C, Darius H, Pittrow D, et al. Knöchel-Arm-Index: ein wegweisender Risikomarker für die hausärztliche Praxis. Dtsch Ärztebl 2005;102:A2310-3.
139. Budoff MJ, Georgiou D, Brody A, et al. Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: a multicenter study. Circulation 1996;93:898-904.
140. Budoff MJ, Diamond GA, Raggi P, et al. Continuous probabilistic prediction of angiographically significant coronary artery disease using electron beam tomography. Circulation 2002;105:1791-6.
141. Knez A, Becker A, Leber A, et al. Relation of coronary calcium scores by electron beam tomography to obstructive disease in 2,115 symptomatic patients. Am J Cardiol 2004;93:1150-2.
142. Wackers FJ, Young LH, Inzucchi SE, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD Study. Diabetes Care 2004;27:1954-61.
143. Hachamovitch R, Hayes SW, Friedman JD, et al. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107:2900-7.
144. Anand DV, Lim E, Raval U, et al. Prevalence of silent myocardial ischemia in asymptomatic individuals with subclinical atherosclerosis detected by electron beam tomography. J Nucl Cardiol 2004;11:450-7.
145. The EUROASPIRE I and II Group. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events. Lancet 2001;357:995-1001.
146. Wong ND, Detrano RC, Diamond G, et al. Does coronary artery screening by electron beam computed tomography motivate potentially beneficial lifestyle behaviors? Am J Cardiol 1996;78:1220-3.
147. O'Malley PG, Feuerstein IM, Taylor AJ. Impact of electron beam tomography, with or without case management, on motivation, behavioral change, and cardiovascular risk profile: a randomized controlled trial. JAMA 2003;289:2215-23.
148. Mozaffarian D. Electron-beam computed tomography for coronary calcium: a useful test to screen for coronary heart disease? JAMA 2005;294:2897-901.
149. Stürzlinger H, Antony K, Pichlbauer E. Koronakalkbestimmung mit CT-Verfahren bei asymptomatischen Risikopatienten. Schriftenreihe Health Technology Assessment (HTA) in der Bundesrepublik Deutschland. Köln: Deutsches Institut für Medizinische Dokumentation und Information (DIMDI), 2006 (http://www.dimdi.de).
150. Schmermund A, Möhlenkamp S, Stang A, et al. Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk Factors, Evaluation of Coronary Calcium and Lifestyle. Am Heart J 2002;144:212-18.